Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Transient neonatal myasthenia gravis (MG) is a rare form of MG occurring in neonates born to mothers who have the disorder or specific circulating autoantibodies.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
9 publications have been identified in PubMed for transient neonatal myasthenia gravis. Research spans Review / Meta-Analysis (50%), Epidemiology / Natural History (25%), and Case Report / Case Series (13%).
Gerede A (2026). [PMID: 41897632](https://pubmed.ncbi.nlm.nih.gov/41897632/). *Diagnostics (Basel, Switzerland)*. [Review / Meta-Analysis]
Garg M (2026). [PMID: 41817069](https://pubmed.ncbi.nlm.nih.gov/41817069/). *Neurology India*. [Review / Meta-Analysis]
Miegel L (2026). [PMID: 41787190](https://pubmed.ncbi.nlm.nih.gov/41787190/). *Journal of neurology*. [Review / Meta-Analysis]
Wang K (2025). [PMID: 40761829](https://pubmed.ncbi.nlm.nih.gov/40761829/). *BMJ neurology open*. [Clinical Trial Publication]
Lindroos JLV (2025). [PMID: 41026991](https://pubmed.ncbi.nlm.nih.gov/41026991/). *Neurology*. [Epidemiology / Natural History]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:16 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Draxler J (2024). [PMID: 38492082](https://pubmed.ncbi.nlm.nih.gov/38492082/). *Archives of gynecology and obstetrics*. [Epidemiology / Natural History]
Alfaidi N (2024). [PMID: 38724842](https://pubmed.ncbi.nlm.nih.gov/38724842/). *CNS drugs*. [Review / Meta-Analysis]
Dan AM (2024). [PMID: 39457179](https://pubmed.ncbi.nlm.nih.gov/39457179/). *Children (Basel, Switzerland)*. [Case Report / Case Series]
AI-curated news mentioning transient neonatal myasthenia gravis
Updated Sep 7, 2026
A population-based study examines medication use trajectories during pregnancies in women with myasthenia gravis. This research provides insights into treatment patterns and potential implications for maternal and fetal health.
A nationwide cohort study highlights the prevalence of non-motor symptoms and healthcare utilization prior to the diagnosis of myasthenia gravis. This research underscores the need for increased awareness and early detection strategies for this rare disease.
A prespecified analysis from the Phase 3 trial of inebilizumab for myasthenia gravis highlights its effectiveness in managing exacerbations and rescue therapy. This study contributes valuable insights into treatment strategies for this rare neuromuscular disorder.